Displaying drugs 1 - 25 of 153 in total
PF-06821497
PF-06821497 is under investigation in clinical trial NCT03460977 (PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma).
Investigational
Matched Name: … PF-06821497 …
Matched Description: … PF-06821497 is under investigation in clinical trial NCT03460977 (PF-06821497 Treatment Of Relapsed/Refractory …
Matched Description: … PF-06821497 is under investigation in clinical trial NCT03460977 (PF-06821497 Treatment Of Relapsed/Refractory …
PF-06282999
Pf 06282999 is under investigation in clinical trial NCT01626976 (A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects).
Investigational
Matched Name: … PF-06282999 …
Matched Description: … And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects). ... Pf 06282999 is under investigation in clinical trial NCT01626976 (A Study To Assess The Safety, Tolerability …
Matched Description: … And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects). ... Pf 06282999 is under investigation in clinical trial NCT01626976 (A Study To Assess The Safety, Tolerability …
PF-05089771
PF-05089771 is under investigation in clinical trial NCT01529671 (A Safety And Tolerability Study Of PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee).
Investigational
Matched Name: … PF-05089771 …
Matched Description: … PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee). ... PF-05089771 is under investigation in clinical trial NCT01529671 (A Safety And Tolerability Study Of …
Matched Description: … PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee). ... PF-05089771 is under investigation in clinical trial NCT01529671 (A Safety And Tolerability Study Of …
PF-04937319
PF-04937319 is under investigation in clinical trial NCT01513928 (A Study To Compare The Pharmacokinetics Of Different Formulations Of PF-04937319 In Healthy Subjects).
Investigational
Matched Name: … PF-04937319 …
Matched Description: … Of Different Formulations Of PF-04937319 In Healthy Subjects). ... PF-04937319 is under investigation in clinical trial NCT01513928 (A Study To Compare The Pharmacokinetics …
Matched Description: … Of Different Formulations Of PF-04937319 In Healthy Subjects). ... PF-04937319 is under investigation in clinical trial NCT01513928 (A Study To Compare The Pharmacokinetics …
PF-06751979
PF-06751979 is under investigation in clinical trial NCT03126721 (The Study is to Evaluate the Effect of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults).
Investigational
Matched Name: … PF-06751979 …
Matched Description: … of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults). ... PF-06751979 is under investigation in clinical trial NCT03126721 (The Study is to Evaluate the Effect …
Matched Description: … of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults). ... PF-06751979 is under investigation in clinical trial NCT03126721 (The Study is to Evaluate the Effect …
PF-06650833
PF-06650833 is under investigation in clinical trial NCT02609139 (Study to Evaluate Pharmacokinetics of A Modified Release Formulation of PF-06650833 in Healthy Subjects).
Investigational
Matched Name: … PF-06650833 …
Matched Description: … of A Modified Release Formulation of PF-06650833 in Healthy Subjects). ... PF-06650833 is under investigation in clinical trial NCT02609139 (Study to Evaluate Pharmacokinetics …
Matched Description: … of A Modified Release Formulation of PF-06650833 in Healthy Subjects). ... PF-06650833 is under investigation in clinical trial NCT02609139 (Study to Evaluate Pharmacokinetics …
PF-06882961
PF-06882961 is under investigation in clinical trial NCT03985293 (A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus).
Investigational
Matched Name: … PF-06882961 …
Matched Description: … and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus). ... PF-06882961 is under investigation in clinical trial NCT03985293 (A 16 Week Study to Evaluate the Efficacy …
Matched Description: … and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus). ... PF-06882961 is under investigation in clinical trial NCT03985293 (A 16 Week Study to Evaluate the Efficacy …
PF-04856884
PF-04856884 or CVX-060 is a selective angiopoietin (Ang)-2 inhibitor. It is under investigation in clinical trial NCT01441414 (PF-04856884 (CVX-060) in Combination With Axitinib in Patients With Previously Treated Metastatic Renal Cell Carcinoma).
Investigational
Matched Name: … PF-04856884 …
Matched Description: … PF-04856884 or CVX-060 is a selective angiopoietin (Ang)-2 inhibitor. ... [A257291] It is under investigation in clinical trial NCT01441414 (PF-04856884 (CVX-060) in Combination …
Matched Description: … PF-04856884 or CVX-060 is a selective angiopoietin (Ang)-2 inhibitor. ... [A257291] It is under investigation in clinical trial NCT01441414 (PF-04856884 (CVX-060) in Combination …
PF-04447943
PF-04447943 has been investigated for the treatment of Alzheimer's Disease.
Investigational
Matched Name: … PF-04447943 …
Matched Description: … PF-04447943 has been investigated for the treatment of Alzheimer's Disease. …
Matched Description: … PF-04447943 has been investigated for the treatment of Alzheimer's Disease. …
PF-03882845
PF-03882845 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 and Type 2 Diabetic Nephropathy.
Investigational
Matched Name: … PF-03882845 …
Matched Description: … PF-03882845 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 and Type …
Matched Description: … PF-03882845 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 and Type …
PF-04958242
PF-04958242 has been used in trials studying the basic science and treatment of Schizophrenia and Hearing Loss, Sensorineural.
Investigational
Matched Name: … PF-04958242 …
Matched Description: … PF-04958242 has been used in trials studying the basic science and treatment of Schizophrenia and Hearing …
Matched Description: … PF-04958242 has been used in trials studying the basic science and treatment of Schizophrenia and Hearing …
PF-00610355
PF-00610355 has been used in trials studying the treatment of Lung Disease, Moxifloxacin, Pulmonary Disease, Asthma, Bronchial, and Bronchial Diseases, among others.
Investigational
Matched Name: … PF-00610355 …
Matched Description: … PF-00610355 has been used in trials studying the treatment of Lung Disease, Moxifloxacin, Pulmonary Disease …
Matched Description: … PF-00610355 has been used in trials studying the treatment of Lung Disease, Moxifloxacin, Pulmonary Disease …
PF-04691502
PF-04691502 has been used in trials studying the treatment of Cancer, Breast Neoplasms, Early Breast Cancer (Phase 2), and Advanced Breast Cancer (Phase 1b).
Investigational
Matched Name: … PF-04691502 …
Matched Description: … PF-04691502 has been used in trials studying the treatment of Cancer, Breast Neoplasms, Early Breast …
Matched Description: … PF-04691502 has been used in trials studying the treatment of Cancer, Breast Neoplasms, Early Breast …
PF-03635659
Pf03635659 has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease.
Investigational
Matched Name: … PF-03635659 …
Matched Description: … Pf03635659 has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease. …
Matched Description: … Pf03635659 has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease. …
PF-05241328
PF-05241328 is under investigation in clinical trial NCT01165736 (To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound Which Will Not Have Any Pharmacological Activity).
Investigational
Matched Name: … PF-05241328 …
Matched Description: … PF-05241328 is under investigation in clinical trial NCT01165736 (To Calculate the Pharmacokinetics ( …
Matched Description: … PF-05241328 is under investigation in clinical trial NCT01165736 (To Calculate the Pharmacokinetics ( …
PF-06815345
PF-06815345 is under investigation in clinical trial NCT02654899 (Single Dose Study of PF-06815345 in Healthy Subjects).
Investigational
Matched Name: … PF-06815345 …
Matched Description: … PF-06815345 is under investigation in clinical trial NCT02654899 (Single Dose Study of PF-06815345 in …
Matched Description: … PF-06815345 is under investigation in clinical trial NCT02654899 (Single Dose Study of PF-06815345 in …
PF-5190457
PF-5190457 is under investigation in clinical trial NCT01522807 (A Study Of Three PF-05190457 Formulations In Healthy Volunteers).
Investigational
Matched Name: … PF-5190457 …
Matched Description: … PF-5190457 is under investigation in clinical trial NCT01522807 (A Study Of Three PF-05190457 Formulations …
Matched Description: … PF-5190457 is under investigation in clinical trial NCT01522807 (A Study Of Three PF-05190457 Formulations …
PF-05105679
PF-05105679 is under investigation in clinical trial NCT01393652 (Single Dose, Dose Escalation Healthy Volunteers Study Of PF-05105679).
Investigational
Matched Name: … PF-05105679 …
Matched Description: … Volunteers Study Of PF-05105679). ... PF-05105679 is under investigation in clinical trial NCT01393652 (Single Dose, Dose Escalation Healthy …
Matched Description: … Volunteers Study Of PF-05105679). ... PF-05105679 is under investigation in clinical trial NCT01393652 (Single Dose, Dose Escalation Healthy …
PF-04620110
PF-04620110 is under investigation in clinical trial NCT01146327 (A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects).
Investigational
Matched Name: … PF-04620110 …
Matched Description: … PF-04620110 is under investigation in clinical trial NCT01146327 (A Multiple Dose Study Of PF-04620110 …
Matched Description: … PF-04620110 is under investigation in clinical trial NCT01146327 (A Multiple Dose Study Of PF-04620110 …
PF-06700841
PF-06700841 is under investigation in clinical trial NCT03236493 (Safety and Pharmacokinetic Study of PF-06700841 in Japanese Healthy Volunteers).
Investigational
Matched Name: … PF-06700841 …
Matched Description: … PF-06700841 in Japanese Healthy Volunteers). ... PF-06700841 is under investigation in clinical trial NCT03236493 (Safety and Pharmacokinetic Study of …
Matched Description: … PF-06700841 in Japanese Healthy Volunteers). ... PF-06700841 is under investigation in clinical trial NCT03236493 (Safety and Pharmacokinetic Study of …
PF-04418948
Pf 04418948 is under investigation in clinical trial NCT01002963 (A Study To Investigate The Safety And Toleration Of A Single Dose Of PF-04418948 In Healthy Volunteers).
Investigational
Matched Name: … PF-04418948 …
Matched Description: … Toleration Of A Single Dose Of PF-04418948 In Healthy Volunteers). ... Pf 04418948 is under investigation in clinical trial NCT01002963 (A Study To Investigate The Safety And …
Matched Description: … Toleration Of A Single Dose Of PF-04418948 In Healthy Volunteers). ... Pf 04418948 is under investigation in clinical trial NCT01002963 (A Study To Investigate The Safety And …
PF-04634817
PF-04634817 is under investigation in clinical trial NCT01140672 (A Multiple Dose Study To Determine Safety, Tolerability, and Pharmacokinetics Of PF-04634817 In Healthy Adult Subjects).
Investigational
Matched Name: … PF-04634817 …
Matched Description: … Safety, Tolerability, and Pharmacokinetics Of PF-04634817 In Healthy Adult Subjects). ... PF-04634817 is under investigation in clinical trial NCT01140672 (A Multiple Dose Study To Determine …
Matched Description: … Safety, Tolerability, and Pharmacokinetics Of PF-04634817 In Healthy Adult Subjects). ... PF-04634817 is under investigation in clinical trial NCT01140672 (A Multiple Dose Study To Determine …
PF-05212377
PF-05212377 is under investigation in clinical trial NCT01712074 (Study Evaluating Thesafety and Efficacy of PF-05212377 or Placebo in Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms on Donepezil).
Investigational
Matched Name: … PF-05212377 …
Matched Description: … PF-05212377 is under investigation in clinical trial NCT01712074 (Study Evaluating Thesafety and Efficacy ... of PF-05212377 or Placebo in Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms …
Matched Description: … PF-05212377 is under investigation in clinical trial NCT01712074 (Study Evaluating Thesafety and Efficacy ... of PF-05212377 or Placebo in Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms …
PF-04995274
Pf 04995274 is under investigation in clinical trial NCT01193062 (Study In Healthy Subjects To Evaluate The Changes In The Protein sAPP-Alpha In Cerebrospinal Fluid Following A Single Oral Dose Of PF-04995274).
Investigational
Matched Name: … PF-04995274 …
Matched Description: … Pf 04995274 is under investigation in clinical trial NCT01193062 (Study In Healthy Subjects To Evaluate ... The Changes In The Protein sAPP-Alpha In Cerebrospinal Fluid Following A Single Oral Dose Of PF-04995274 …
Matched Description: … Pf 04995274 is under investigation in clinical trial NCT01193062 (Study In Healthy Subjects To Evaluate ... The Changes In The Protein sAPP-Alpha In Cerebrospinal Fluid Following A Single Oral Dose Of PF-04995274 …
PF-03758309
PF-03758309 has been used in trials studying the treatment of Advanced Solid Tumors.
Investigational
Matched Name: … PF-03758309 …
Matched Description: … PF-03758309 has been used in trials studying the treatment of Advanced Solid Tumors. …
Matched Salts name: … Pf 03758309 Hydrochloride …
Matched Description: … PF-03758309 has been used in trials studying the treatment of Advanced Solid Tumors. …
Matched Salts name: … Pf 03758309 Hydrochloride …
Displaying drugs 1 - 25 of 153 in total